Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
about
Selected cytokine pathways in rheumatoid arthritis.Intracellular B Lymphocyte Signalling and the Regulation of Humoral Immunity and Autoimmunity.Searching Novel Therapeutic Targets for Scleroderma: P2X7-Receptor Is Up-regulated and Promotes a Fibrogenic Phenotype in Systemic Sclerosis Fibroblasts.Neuroendocrine and neurophysiological effects of interleukin 6 in rheumatoid arthritis.
P2860
Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
description
2016 nî lūn-bûn
@nan
2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
@ast
Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
@en
Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
@nl
type
label
Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
@ast
Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
@en
Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
@nl
prefLabel
Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
@ast
Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
@en
Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
@nl
P2093
P2860
P921
P3181
P356
P1476
Spotlight on sirukumab for the treatment of rheumatoid arthritis: the evidence to date
@en
P2093
Enrico Selvi
Franco Laghi-Pasini
Giacomo Maria Guidelli
Pier Leopoldo Capecchi
Pietro Enea Lazzerini
P2860
P304
P3181
P356
10.2147/DDDT.S99898
P407
P5008
P577
2016-09-26T00:00:00Z